secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0001193125-21-311319
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio terminates collaboration agreement with SPARCBIO LLC effective Jan 2022
--------------------------------------------------------------------------------

- On Oct 22, 2021, Nuvation notified SPARCBIO LLC of termination effective Jan 21, 2022 without penalty.
- The collaboration agreement was originally dated Jan 21, 2019 among Nuvation, RePharmation, and SPARCBIO LLC.
- Company stated it no longer requires the services under the collaboration agreement.
- No additional costs, penalties, or new agreements were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312521311319/0001193125-21-311319-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312521311319/d162622d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-311319

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer